Legal & General Group Plc Purchases 2,031 Shares of Spok Holdings, Inc. (NASDAQ:SPOK)

Legal & General Group Plc boosted its position in shares of Spok Holdings, Inc. (NASDAQ:SPOK) by 57.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,546 shares of the Wireless communications provider’s stock after acquiring an additional 2,031 shares during the period. Legal & General Group Plc’s holdings in Spok were worth $89,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of SPOK. Geode Capital Management LLC grew its position in shares of Spok by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 514,427 shares of the Wireless communications provider’s stock valued at $8,258,000 after purchasing an additional 6,591 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Spok by 7.6% in the 4th quarter. JPMorgan Chase & Co. now owns 213,575 shares of the Wireless communications provider’s stock valued at $3,428,000 after acquiring an additional 15,156 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Spok by 67.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 110,997 shares of the Wireless communications provider’s stock valued at $1,782,000 after acquiring an additional 44,896 shares in the last quarter. Trexquant Investment LP boosted its position in shares of Spok by 49.8% during the 4th quarter. Trexquant Investment LP now owns 106,467 shares of the Wireless communications provider’s stock valued at $1,709,000 after acquiring an additional 35,401 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Spok by 133.9% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 105,241 shares of the Wireless communications provider’s stock worth $1,689,000 after purchasing an additional 60,256 shares during the last quarter. Institutional investors own 50.81% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. StockNews.com raised shares of Spok from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. B. Riley upgraded shares of Spok from a “neutral” rating to a “buy” rating and upped their target price for the stock from $15.00 to $20.00 in a research report on Thursday, February 27th.

Spok Price Performance

Shares of SPOK opened at $16.23 on Friday. The firm has a market cap of $331.40 million, a P/E ratio of 22.23 and a beta of 0.40. Spok Holdings, Inc. has a 1 year low of $13.24 and a 1 year high of $17.96. The stock has a 50 day simple moving average of $15.84 and a two-hundred day simple moving average of $16.02.

Spok (NASDAQ:SPOK) last issued its earnings results on Wednesday, April 30th. The Wireless communications provider reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.07. Spok had a net margin of 10.66% and a return on equity of 9.20%. The company had revenue of $36.29 million for the quarter, compared to analysts’ expectations of $34.00 million. On average, equities analysts anticipate that Spok Holdings, Inc. will post 0.76 earnings per share for the current year.

Spok Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Friday, May 23rd will be paid a dividend of $0.3125 per share. This represents a $1.25 dividend on an annualized basis and a dividend yield of 7.70%. The ex-dividend date is Friday, May 23rd. Spok’s dividend payout ratio (DPR) is presently 168.92%.

Spok Company Profile

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.